As of 2025-07-04, the Relative Valuation of Silverback Therapeutics Inc (SBTX) is (28.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.87 USD, the upside of Silverback Therapeutics Inc based on Relative Valuation is -589.1%.
The range of the Relative Valuation is (24.14) - (28.43) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.4x - 29.6x | 27.0x |
| Forward P/E multiples | 25.1x - 41.6x | 32.7x |
| Fair Price | (24.14) - (28.43) | (28.71) |
| Upside | -511.3% - -584.4% | -589.1% |
| Date | P/E |